See All Slides - tctmd.com

Slides

Presentation TCT 2013

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Presenter: David Erlinge

October 30, 2013

Presentation TCT 2013

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Presenter: Gilles Montalescot

October 30, 2013

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Presentation TCT 2013

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Presenter: Robert Whitbourn

October 30, 2013

Presentation TCT 2013

Climbing the Academic Ladder: Pitfalls and Triumphs

Presenter: J. Dawn Abbott

October 30, 2013

Presentation TCT 2013

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Presenter: Christy Foreman

October 30, 2013

Presentation TCT 2013

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Are Sham Controls Needed for Future Renal Denervation Studies?

Presenter: Ajay Kirtane

October 30, 2013

Presentation TCT 2013

Focusing Our Priorities: Moving From the Vulnerable Plaque to the Vulnerable Patient

Presenter: Valentin Fuster

October 30, 2013

Advertisement

Slides

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Climbing the Academic Ladder: Pitfalls and Triumphs

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Are Sham Controls Needed for Future Renal Denervation Studies?

Focusing Our Priorities: Moving From the Vulnerable Plaque to the Vulnerable Patient

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content